This press release has been updated.
Click
here for more information
Hemispherx Biopharma will give an update on its Influenza research initiatives
through teleconference on Wednesday.
http://StockEinstein.com offers free daily stock alerts on companies
ready to run. Scroll to the bottom of this page to signup for free stock
alerts and visit our site.
Hemispherx's Medical Director, CEO, and the Managing Director of the Sage
Group, a health care consulting firm retained by Hemispherx, will participate
in the event.
StockEinstein.com has a
dedicated team uncovering stocks ready to break and run. We apply time
tested criteria and when one of these stocks meets or exceeds our benchmarks,
our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to
signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or
website unless you can afford the loss of your entire investment. Stocks
and particularly penny stocks have the possibility for dramatic gains, and also
losses. Neither StockEinstein, nor any of its affiliates are registered
investment advisors or broker dealers.
